List of insiders holdings for MACROGENICS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| BIOTECH TARGET N V BB BIOTECH AG 10% Owner | 2024-02-13 06:13:55 | 9,929,963 0 | 9,929,963 | Form 13G |
| ORONSKY ARNOLD L Director | 2014-02-18 16:03:27 | 0 1,708,716 | 1,708,716 | Form 4 |
| INTERWEST PARTNERS VIII LP InterWest Management Partners VIII LLC INTERWEST INVESTORS VIII L P INTERWEST INVESTORS Q VIII LP CASH HARVEY B GIANOS PHILIP T Kliman Gilbert H HEDRICK W SCOTT Holmes W Stephen 10% Owner | 2015-02-13 06:18:59 | 1,282,303 0 | 1,282,303 | Form 13G |
| Koenig Scott President and CEO | 2024-10-09 16:26:37 | 0 427,480 | 427,480 | Form 4 |
| Risser Eric Blasius Chief Operating Officer | 2024-03-06 16:20:36 | 193,900 0 | 193,900 | Form 4 |
| Karrels James SVP, CFO and Secretary | 2024-03-06 16:18:40 | 171,452 0 | 171,452 | Form 4 |
| Peters Jeffrey Stuart Senior VP and General Counsel | 2024-04-08 18:07:30 | 127,500 0 | 127,500 | Form 4 |
| Bonvini Ezio Sr VP, Research & CSO | 2024-02-26 16:26:26 | 100,892 0 | 100,892 | Form 4 |
| Wigginton Jon Marc Sr VP, Clinical Dev. & CMO | 2020-02-24 16:46:33 | 100,000 0 | 100,000 | Form 4 |
| Stein Kathryn E SVP, Product Dev. & Regulatory | 2016-01-11 13:39:46 | 95,555 0 | 95,555 | Form 4 |
| Spitznagel Thomas Sr VP, Technical Ops | 2024-03-06 16:19:33 | 85,316 0 | 85,316 | Form 4 |
| Chhabra Meenu Director | 2024-05-23 17:18:17 | 56,577 0 | 56,577 | Form 4 |
| Eck Stephen L. Chief Medical Officer | 2024-02-20 18:41:46 | 43,128 0 | 43,128 | Form 4 |
| ALTA BIOPHARMA PARTNERS III LP ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC 10% Owner | 2016-02-12 17:24:27 | 27,630 0 | 27,630 | Form 13G |
| Jackson Scott Thomas Director | 2024-05-23 17:16:03 | 23,000 0 | 23,000 | Form 4 |
| HURWITZ EDWARD Director | 2024-05-23 17:16:25 | 23,000 0 | 23,000 | Form 4 |
| HEIDEN WILLIAM K Director | 2024-05-23 17:16:44 | 23,000 0 | 23,000 | Form 4 |
| STUMP DAVID C Director | 2024-05-23 17:16:58 | 23,000 0 | 23,000 | Form 4 |
| Ferrante Karen Jean Director | 2024-05-23 17:17:13 | 23,000 0 | 23,000 | Form 4 |
| O'Brien Federica F. Director | 2024-05-23 17:17:58 | 23,000 0 | 23,000 | Form 4 |
| SIEGEL JAY PHILIP Director | 2024-05-23 17:18:36 | 23,000 0 | 23,000 | Form 4 |
| Cilinski Lynn VP, Controller and Treasurer | 2024-02-20 18:04:45 | 19,545 0 | 19,545 | Form 4 |
| SARAN ATUL SVP & General Counsel | 2017-05-02 12:58:29 | 16,986 0 | 16,986 | Form 4 |
| Liu Margaret Director | 2024-05-24 17:08:21 | 16,500 0 | 16,500 | Form 4/A |
| Stewart Stanford John V P, Clinical Oncology | 2013-10-11 16:46:03 | 15,979 0 | 15,979 | Form 4 |
| Galbraith Kenneth Director | 2021-05-17 21:20:23 | 15,000 0 | 15,000 | Form 4 |
| Costa Paulo F Director | 2021-05-17 21:17:27 | 15,000 0 | 15,000 | Form 4 |
| Nadav Eran Director | 2013-10-11 16:54:29 | 13,849 0 | 13,849 | Form 4 |
| Fust Matthew K Director | 2019-05-20 17:47:34 | 10,000 0 | 10,000 | Form 4 |
| TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G Former 10% Owner | 2015-02-13 12:35:06 | 0 0 | 0 | Form 13G |